Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression
Journal of Affective Disorders · 2024
DOI: 10.1016/j.jad.2024.07.025 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Affective Disorders, 2024. Verfasst von Patricia Andrews und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA. Hauptthemen laut MEDLINE: Affect, Antidepressive Agents, Executive Function, Nicotine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, NCATS NIH HHS, National Institute of Mental Health.
Themen: Depression
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA.
- Center for Cognitive Medicine, Department of Psychiatry and Behavioral Science, Vanderbilt University Medical Center, Nashville, TN, USA; Geriatric Research, Education, and Clinical Center, Veterans Affairs Tennessee Va…
- Departments of Pharmacology, Toxicology, and Psychiatry, University of Toronto, and the Centre for Addiction and Mental Health, Toronto, ON, Canada.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
- Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, New York, NY, USA.
Förderung
- NIMH NIH HHS
- NCATS NIH HHS
- National Institute of Mental Health
- National Institutes of Health
- American Association for Geriatric Psychiatry
- National Center for Advancing Translational Sciences
Zitieren
APA
Andrews, P., Vega, J. N., Szymkowicz, S. M., Newhouse, P., Tyndale, R., Elson, D., Kang, H., Siddiqi, S., Tyner, E. B., Mather, K., Gunning, F. M., & Taylor, W. D. (2024). Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.07.025
Vancouver
Andrews P, Vega JN, Szymkowicz SM, Newhouse P, Tyndale R, Elson D, et al. Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression. Journal of Affective Disorders. 2024. doi:10.1016/j.jad.2024.07.025
BibTeX
@article{Andrews2024,
author = {Andrews, Patricia and Vega, Jennifer N and Szymkowicz, Sarah M and Newhouse, Paul and Tyndale, Rachel and Elson, Damian and Kang, Hakmook and Siddiqi, Sarah and Tyner, Elizabeth B and Mather, Kathleen and Gunning, Faith M and Taylor, Warren D},
title = {Effects of open-label transdermal nicotine antidepressant augmentation on affective symptoms and executive function in late-life depression},
journal = {Journal of Affective Disorders},
year = {2024},
doi = {10.1016/j.jad.2024.07.025}
}
EUVIMED